22,640 Shares in Avanos Medical, Inc. (NYSE:AVNS) Bought by King Luther Capital Management Corp

King Luther Capital Management Corp acquired a new stake in shares of Avanos Medical, Inc. (NYSE:AVNS) during the 3rd quarter, HoldingsChannel reports. The fund acquired 22,640 shares of the company’s stock, valued at approximately $544,000.

Several other institutional investors have also modified their holdings of the stock. Paradice Investment Management LLC raised its holdings in shares of Avanos Medical by 5.4% during the second quarter. Paradice Investment Management LLC now owns 1,344,949 shares of the company’s stock valued at $26,791,000 after acquiring an additional 69,389 shares during the last quarter. AQR Capital Management LLC raised its stake in Avanos Medical by 21.0% in the 2nd quarter. AQR Capital Management LLC now owns 146,983 shares of the company’s stock valued at $2,875,000 after purchasing an additional 25,467 shares during the last quarter. Public Sector Pension Investment Board lifted its holdings in Avanos Medical by 6.1% in the 2nd quarter. Public Sector Pension Investment Board now owns 100,957 shares of the company’s stock valued at $2,011,000 after purchasing an additional 5,793 shares in the last quarter. Federated Hermes Inc. boosted its stake in Avanos Medical by 4.2% during the 2nd quarter. Federated Hermes Inc. now owns 97,097 shares of the company’s stock worth $1,934,000 after purchasing an additional 3,938 shares during the last quarter. Finally, American Century Companies Inc. grew its holdings in shares of Avanos Medical by 12.1% during the second quarter. American Century Companies Inc. now owns 82,930 shares of the company’s stock worth $1,652,000 after buying an additional 8,929 shares in the last quarter. Institutional investors and hedge funds own 95.17% of the company’s stock.

Avanos Medical Trading Up 3.2 %

Shares of Avanos Medical stock opened at $18.60 on Friday. Avanos Medical, Inc. has a 1-year low of $17.39 and a 1-year high of $25.36. The company has a debt-to-equity ratio of 0.12, a current ratio of 2.22 and a quick ratio of 1.46. The stock has a market cap of $854.86 million, a P/E ratio of 54.71 and a beta of 0.92. The stock’s 50 day simple moving average is $21.73 and its 200-day simple moving average is $21.53.

Wall Street Analysts Forecast Growth

Separately, StockNews.com downgraded shares of Avanos Medical from a “strong-buy” rating to a “buy” rating in a research note on Sunday, November 3rd.

About Avanos Medical

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.